Iris Roth

Insider Reports History

Entity
Individual
Location
C/O Zentalis Pharmaceuticals, Inc., 530 Seventh Avenue, Suite 2201, New York, NY
Signature
/s/ Andrea Paul, attorney-in-fact for Iris Roth
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Iris Roth:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Zentalis Pharmaceuticals, Inc. Chief Operating Officer Stock Option (Right to Buy) 298K $14.2M $47.80 Mar 1, 2023 Direct
Zentalis Pharmaceuticals, Inc. Chief Operating Officer Common Stock 52.5K $540K $10.29 Mar 1, 2023 Direct

Insider Reports Filed by Iris Roth

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ZNTL Zentalis Pharmaceuticals, Inc. Mar 1, 2023 2 $0 4 Mar 2, 2023 Chief Operating Officer
ZNTL Zentalis Pharmaceuticals, Inc. Feb 13, 2023 0 $0 3 Feb 13, 2023 Chief Operating Officer